0001127602-24-013976.txt : 20240502
0001127602-24-013976.hdr.sgml : 20240502
20240502162217
ACCESSION NUMBER: 0001127602-24-013976
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240430
FILED AS OF DATE: 20240502
DATE AS OF CHANGE: 20240502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Guindo Chirfi
CENTRAL INDEX KEY: 0001722753
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 24908701
MAIL ADDRESS:
STREET 1: C/O BIOGEN INC.
STREET 2: 225 BINNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-04-30
0000310158
Merck & Co., Inc.
MRK
0001722753
Guindo Chirfi
MERCK & CO., INC.
126 EAST LINCOLN AVENUE
RAHWAY
NJ
07065
1
Chief Marketing Officer
0
Common Stock
20753.241
D
Common Stock-401(k) Plan
53.4868
I
By 401(k)
Stock Option (Right to Buy)
129.22
2024-04-30
4
A
0
29297
0
A
2025-04-30
2034-04-29
Common Stock
29297
29297
D
Holdings include shares acquired in dividend reinvestment transactions.
Includes shares acquired and dividends earned through April 5, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.
The option vests and becomes exercisable in equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.
/s/ Kelly Grez, as attorney-in-fact for Mr. Chirfi Guindo
2024-05-02